
Another weight loss jab has been given the green light for NHS use, with about 180,000 people with type 2 diabetes expected to benefit.
Tirzepatide – also known as Mounjaro – can be used as an option for those who do not have the condition under control, the National Institute for Health and Care Excellence (Nice) said.